Tree of Knowledge Goes Public on the CSE Backed by Strong Management Team and Advisory Board

Tree of Knowledge International Corp. (CSE: TOKI) (OTC: TRKWF) recently began trading on the Canadian Securities Exchange, or CSE, following the reverse merger of Courtland Capital Inc. by private Nevada company Tree of Knowledge Inc.

Investors interested in capitalizing on the growing demand for cannabidiol (CBD) from hemp-based sources may want to take a closer look at the company — particularly given its strong management team and advisory board. According to the Hemp Business Journal, U.S. hemp-based product sales could reach nearly $2 billion by 2022, making it one of the fastest growing segments in the burgeoning cannabis space.

Since its start in 2011, Tree of Knowledge has grown to become a leading producer and distributor of CBD rich hemp oil, capsules, tinctures, salvation balms, and other hemp-based products designed to provide consumers with a high-quality source of cannabidiol (CBD) — even in jurisdictions where marijuana isn’t legal, including much of Europe and Asia. CBD can be derived from either marijuana or hemp, and when it is derived from USDA approved industrial hemp, there is protection under US Farm Bill legislation from enforcement action by regulators in the US.

The company’s products consist of hemp-based CBD cannabinoids along with other organic, gluten-free, and vegan natural ingredients. After using a third party to test all of its products, the company labels each product with a QR code where customers can login and see the Certificate of Analysis to confirm purity and be assured that there are no pesticides, microbial, or heavy metals in the product. These products are sold throughout North America, South America, Asia, and Europe, with support from many medical professionals.

The company also plans on launching an innovative genetic enzyme marking technology in the near-term to help healthcare practitioners read the genetic disposition of a patient to see how they will metabolize various cannabinoids. In addition, the company’s exclusive BrainBot™ license also enables it to provide healthcare practitioners with an EEG headband to see how cannabinoids affect patients. These tools could make it easier for healthcare practitioners to recommend hemp-based products to their patients.

Brian Main and Michael Caridi founded Tree of Knowledge as a small boutique hemp oil operation in 2011 that has become an internationally recognized firm.

Mr. Main began his career in the U.S. Marine Corps in a security role guarding classified materials with an ETNAC-5 security clearance. After serving his country, he studied microbiological genetic technologies at Eastern Washington University before being recalled to duty in Operation Desert Storm in 1991. Upon returning, he worked in the family real estate business before starting several of his own ventures in the mid 1990s. He has focused exclusively on the medical marijuana and industrial hemp industries since 2011.

Mr. Caridi is the Managing Director of Bedford Capital Partners, which specializes in business development and consulting across various industries. With over $200 million in deal flow in his career, Mr. Caridi has held roles in the development of diabetic, Alzheimer’s diseases, and regenerative skin companies, as well as worked in real estate projects, such as the demilitarization and scrapping of the USS Bennington aircraft carrier and various construction projects with Fortune 500 companies over several years.

These two co-founders are well positioned to grow the company over the coming years given their extensive expertise across many different industries in the past.

Tree of Knowledge has amassed a strong advisory board following its success in growing its operations around the world.

Dr. Sanjay Gupta is perhaps one of the most well known advisory board members. In addition to serving as President of DrCircle.com, he has appeared on various television platforms and as the Director of Health Time TV, comprised of more than 160,000 medical professionals. He is a Harvard trained pain specialist and President of the American Pain Association, as well as an outspoken proponent of medical marijuana and its role in fighting the opioid epidemic.

Ambassador Jack Brewer is also very well known as a NFL player for the Minnesota Vikings. After a career as an exceptional special teams player and versatile defensive back, he accepted a position as a wealth manager at Merrill Lynch in the Global Private Equity Client Group in New York City. He then struck out on his own as the CEO and Portfolio Manager of The Brewer Group, which makes investments into private and public companies across many different vertical markets.

Christopher Kaplan has over 25 years experience in life sciences with a successful track record that covers R&D, operations, strategy, business development and M&A. He has pioneered new drug development activities in support of a more personalized medicine approach to patients care. Throughout half of his career, he lived and worked outside of the U.S., providing TOK/EVR with a strong global biopharma perspective. He has also held significant Global, European, and US leadership roles at Bristol-Myers Squibb, Novartis, Boehringer-Ingelheim, and most recently, as Senior Vice President and Head of North American for Sanofi. Chris holds a Bachelor’s degree from Columbia University and a Masters degree from the University of Pennsylvania.

The company also has several other advisory board members that have strong expertise throughout the cannabis industry supply chain and related industries. This experience will help guide the company as it continues to make progress building out its business presence around the world.

Tree of Knowledge International Corp. (CSE: TOKI) represents a compelling investment opportunity in the global hemp industry. After going public on the CSE, the company’s strong management team and advisory board are well positioned to capitalize on the growing demand for hemp-based products and ultimately build long-term value for shareholders. Management expects to generate $5.3 million and $28 million in revenue in 2018 and 2019, respectively, before reaching $49 million in revenue by 2020.

For more information, visit the company’s website at www.evrcbd.com.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.